Detalhe da pesquisa
1.
The SPPL3-Defined Glycosphingolipid Repertoire Orchestrates HLA Class I-Mediated Immune Responses.
Immunity
; 54(1): 132-150.e9, 2021 01 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33271119
2.
The SPPL3-defined glycosphingolipid repertoire orchestrates HLA class I-mediated immune responses.
Immunity
; 54(2): 387, 2021 Feb 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33567263
3.
Association of Tumor Cell Metabolic Subtype and Immune Response With the Clinical Course of Hepatocellular Carcinoma.
Oncologist
; 28(11): e1031-e1042, 2023 Nov 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37159555
4.
VT68.2: An Antibody to Chondroitin Sulfate Proteoglycan 4 (CSPG4) Displays Reactivity against a Tumor-Associated Carbohydrate Antigen.
Int J Mol Sci
; 24(3)2023 Jan 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36768830
5.
Perspectives in Melanoma: meeting report from the Melanoma Bridge (December 2nd - 4th, 2021, Italy).
J Transl Med
; 20(1): 391, 2022 09 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36058945
6.
Human Hepatitis B Virus Negatively Impacts the Protective Immune Crosstalk Between Natural Killer and Dendritic Cells.
Hepatology
; 74(2): 550-565, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33482027
7.
Integrated Antitumor Activities of Cellular Immunotherapy with CIK Lymphocytes and Interferons against KIT/PDGFRA Wild Type GIST.
Int J Mol Sci
; 23(18)2022 Sep 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36142281
8.
A monocentric phase I study of vemurafenib plus cobimetinib plus PEG-interferon (VEMUPLINT) in advanced melanoma patients harboring the V600BRAF mutation.
J Transl Med
; 19(1): 17, 2021 01 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33407577
9.
Perspectives in Melanoma: meeting report from the Melanoma Bridge (December 3rd-5th, 2020, Italy).
J Transl Med
; 19(1): 278, 2021 06 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34193182
10.
Defective HLA Class I Expression and Patterns of Lymphocyte Infiltration in Chordoma Tumors.
Clin Orthop Relat Res
; 479(6): 1373-1382, 2021 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33273248
11.
CD16-158-valine chimeric receptor T cells overcome the resistance of KRAS-mutated colorectal carcinoma cells to cetuximab.
Int J Cancer
; 146(9): 2531-2538, 2020 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31396956
12.
In vitro elimination of epidermal growth factor receptor-overexpressing cancer cells by CD32A-chimeric receptor T cells in combination with cetuximab or panitumumab.
Int J Cancer
; 146(1): 236-247, 2020 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31479522
13.
A fast, simple, and cost-effective method of expanding patient-derived xenograft mouse models of pancreatic ductal adenocarcinoma.
J Transl Med
; 18(1): 255, 2020 06 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-32580742
14.
Perspectives in melanoma: meeting report from the "Melanoma Bridge" (December 5th-7th, 2019, Naples, Italy).
J Transl Med
; 18(1): 346, 2020 09 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32894202
15.
Correction to: Induction of immunogenic cell death in radiation-resistant breast cancer stem cells by repurposing anti-alcoholism drug disulfiram.
Cell Commun Signal
; 18(1): 53, 2020 Apr 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32241283
16.
Induction of immunogenic cell death in radiation-resistant breast cancer stem cells by repurposing anti-alcoholism drug disulfiram.
Cell Commun Signal
; 18(1): 36, 2020 03 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32138738
17.
The role of cancer stem cells in the modulation of anti-tumor immune responses.
Semin Cancer Biol
; 53: 189-200, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30261276
18.
High IDO1 Expression Is Associated with Poor Outcome in Patients with Anal Cancer Treated with Definitive Chemoradiotherapy.
Oncologist
; 24(6): e275-e283, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30755500
19.
Addressing current challenges and future directions in immuno-oncology: expert perspectives from the 2017 NIBIT Foundation Think Tank, Siena, Italy.
Cancer Immunol Immunother
; 68(1): 1-9, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30564889
20.
Perspectives in melanoma: meeting report from the Melanoma Bridge (November 29th-1 December 1st, 2018, Naples, Italy).
J Transl Med
; 17(1): 234, 2019 07 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-31331337